PLAU and Parkinson disease: In PD, uPA was found to act as an activator protease in the process of plasminogen activation and upregulate the expression of the serine protease inhibitor (serpin) plasminogen activator inhibitor-1 (PAI-1), leading to neuroinflammation (Reuland and Church, 2020).